Navigation Links
Muscle Spasticity Global Clinical Trials Review, H2, 2014
Date:8/5/2014

NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Muscle Spasticity Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02256140/Muscle-Spasticity-Global-Clinical-Trials-Review-H2-2014.html

Muscle Spasticity Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Muscle Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Muscle Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Muscle Spasticity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Muscle Spasticity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Muscle Spasticity 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Muscle Spasticity to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Muscle Spasticity to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21

In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Muscle Spasticity 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Muscle Spasticity Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Allergan, Inc. 32
Clinical Trial Overview of Allergan, Inc. 32
Ipsen S.A. 34
Clinical Trial Overview of Ipsen S.A. 34
Merz Pharma GmbH & Co. KgaA 35
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 35
Torrent Power Limited 36
Clinical Trial Overview of Torrent Power Limited 36
Sun Pharma Advanced Research Company 37
Clinical Trial Overview of Sun Pharma Advanced Research Company 37
MediciNova, Inc. 38
Clinical Trial Overview of MediciNova, Inc. 38
Acorda Therapeutics, Inc. 39
Clinical Trial Overview of Acorda Therapeutics, Inc. 39

GlaxoSmithKline plc 40
Clinical Trial Overview of GlaxoSmithKline plc 40
Daewoong Co., Ltd. 41
Clinical Trial Overview of Daewoong Co., Ltd. 41
ASIS Corporation 42
Clinical Trial Overview of ASIS Corporation 42
Clinical Trial Overview of Top Institutes / Government 43
National Institute of Neurological Disorders and Stroke 43
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 43
University of Alberta 44
Clinical Trial Overview of University of Alberta 44
Georgetown University 45
Clinical Trial Overview of Georgetown University 45
Medical University of Vienna 46
Clinical Trial Overview of Medical University of Vienna 46
Institut fur Klinisch-Kardiovaskulare Forschung GmbH 47
Clinical Trial Overview of Institut fur Klinisch-Kardiovaskulare Forschung GmbH 47
University of Manitoba 48
Clinical Trial Overview of University of Manitoba 48
Assistance Publique Hopitaux De Marseille 49
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 49

Eunice Kennedy Shriver National Institute of Child Health and Human Development 50
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 50
Vanderbilt University 51
Clinical Trial Overview of Vanderbilt University 51
U.S. Department of Veterans Affairs 52
Clinical Trial Overview of U.S. Department of Veterans Affairs 52
Five Key Clinical Profiles 53
Appendix 114
Abbreviations 114
Definitions 114
Research Methodology 115
Secondary Research 115
About GlobalData 116
Contact Us 116
Disclaimer 116
Source 116

List of Tables

Muscle Spasticity Therapeutics, Global, Clinical Trials by Region, 2014* 7
Muscle Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Muscle Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Muscle Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Muscle Spasticity Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Muscle Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Muscle Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Muscle Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of Muscle Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Muscle Spasticity Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Muscle Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Muscle Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Muscle Spasticity Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Muscle Spasticity Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Muscle Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Muscle Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Muscle Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29

Muscle Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Muscle Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014* 32
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014* 34
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014* 35
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Torrent Power Limited, 2014* 36
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharma Advanced Research Company, 2014* 37
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by MediciNova, Inc., 2014* 38
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014* 39
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 40

Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Daewoong Co., Ltd., 2014* 41
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by ASIS Corporation, 2014* 42
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 43
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2014* 44
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2014* 45
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 46
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut fur Klinisch-Kardiovaskulare Forschung GmbH, 2014* 47
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014* 48
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2014* 49
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 50
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 51
Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 52

List of Figures

Muscle Spasticity Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Muscle Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Muscle Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Muscle Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Muscle Spasticity Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Muscle Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Muscle Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Muscle Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Muscle Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Muscle Spasticity Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Muscle Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Muscle Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Muscle Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Muscle Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Muscle Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Muscle Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Muscle Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 115

To order this report: Muscle Spasticity Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02256140/Muscle-Spasticity-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014
2. aTyr Pharma Announces Publication of a Rare Muscle Disease Associated with Regulation of a Potential Physiocrine
3. MusclePharms Award Winning Amino 1 To Be Available at Costco January 2014
4. Sector Leaders Briefing & Capital Raise News: Muscle Warfare, Baidu, Herblife, Gilead Sciences and ARIAD
5. PTC Therapeutics to Present at World Muscle Society Congress
6. New Evidence Published in Muscle and Nerve on Measuring 6-Minute Walk Distance in Duchenne Muscular Dystrophy
7. Study Shows Honokiol Supports Muscles During Intense Exercise*
8. US Vitamin Injections Posts New Article about the Science of Muscle Building
9. MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete
10. BioElectronics ActiPatch Reduces Muscle Soreness in Runners
11. Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... "Company") (NASDAQ: UNIS ; ASX: UNS), a developer and ... for the second quarter of fiscal 2016 (three months ended December ... Financial Results for the Second Quarter of Fiscal 2016 ... the second quarter of fiscal 2016 was $4.5 million, compared to ... customers for the second quarter of fiscal 2016 were $17.8 million, ...
(Date:2/9/2016)... 2016  Axovant Sciences Ltd. (NYSE:  AXON), a ... of dementia, today announced further details of three ... functional aspects of Lewy body dementia, a disease ... Two out of the three studies were recently ... later this quarter. In addition, the Company reported ...
(Date:2/9/2016)... Hearing protection devices refer to the barriers that reduce ... ear. Hearing protection devices include earplugs, uniform attenuation earplug, ... users exposed to noise levels of over 80 dB ... inserted in the ear canal to protect the ear. ... sound perception with the help of acoustic filters. Earmuffs ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... LLC to help enterprises move workloads to the cloud. Cirracore provides a ... their cloud without traversing the Internet. Transformation Solutions (TSL Partners) provides a ...
(Date:2/9/2016)... ... February 09, 2016 , ... BioPlus Specialty Pharmacy (BioPlus), one ... ‘Pay It Forward’ program into 2016. BioPlus partners with several non-profit patient foundations ... , “Since our Pay It Forward program began, we are proud to have ...
(Date:2/9/2016)... ... ... On January 12, 2016 Paul McElwee, a CroppMetcalfe HVAC technician, visited a home ... any heat. Shortly after entering the home, Paul was able to identify the problem ... carbon monoxide into the home, at 2,000 parts per million in the flue. Anything ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. ... department stores, announced it has raised $176,000 to benefit the Breast Cancer Research ... Center at the University of Iowa, The Lynn Sage Cancer Research Foundation, and ...
Breaking Medicine News(10 mins):